InMode, a leading global provider of innovative medical technologies, has announced its participation in the 2nd Annual BNP Paris Exane Aesthetics Day that will take place on May 21, 2024 in New York, NY. Dr. Spero Theodorou, bodySCULPT®’s Founder and Surgical Director, will represent InMode at this ground-breaking event.
BNP Paribas Exane is well-known for their innovative and high-quality research products including independent, fundamental, long-term equity research. They have been ranked #1 for Industry Research in Developed Europe by the Institutional Investor Survey for seven consecutive years. They connect investors with corporates, and have a dedicated specialist sales team to provide clients deep sector expertise across equities.
Other presenters joining the event along with Dr. Spero are – Moshe Mizrahy, Chief Executive Officer, and Yair Malca, Chief Financial Officer at InMode.
During his presentation, Dr. Spero will explain InMode’s leading technologies such as BodyTite, FaceTite, and Morpheus8, which use radiofrequency-assisted lipolysis and fractional skin resurfacing to deliver unique results in body contouring, facial rejuvenation, and skin tightening. He will also highlight the significance of relentless research and clinical studies in confirming the worth and safety of these advanced treatments.
With a focus on innovation and patient-centric solutions, InMode, for years, has been developing cutting-edge platforms that address a wide range of aesthetic concerns with minimal downtime and optimal results. InMode develops, manufactures, and markets devices harnessing novel RF (Radiofrequency) technology. They strive to enable innovative and emerging surgical procedures and improve current treatments.
In addition to highlighting the capabilities of InMode’s technology, Dr. Spero would also emphasize the significance of ongoing investigations and clinical trials in confirming the effectiveness and security of these cutting-edge medical interventions.
Through partnerships with top medical professionals and research centers across the globe, InMode is dedicated to developing the field of aesthetics science and establishing new benchmarks for superior patient care.